Companies
Biotech Returns To Strength
April 2007 | Industry NewsThe European biotech industry is experiencing strong growth after a period of uncertainty, claims a new report by professional services firm Ernst & Young. According to the study, the sector grew by 13% in 2006 - more than twice the level in 2005 - generating revenues of EUR13.3bn (US$18.01bn). However, figures for expansion are varied with other sources estimating growth of as much as 45%, driven by major acquisitions such as
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
